SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹27 Cr | ₹23 Cr | ₹14 Cr | ₹11 Cr | ₹8.01 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹27 Cr |
| Mar2024 | ₹23 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹8.01 Cr |
How is Deferred Tax Assets / Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹27 Cr | 16.70 | |
| Mar2024 | ₹23 Cr | 69.30 | |
| Mar2023 | ₹14 Cr | 22.66 | |
| Mar2022 | ₹11 Cr | 39.17 | |
| Mar2021 | ₹8.01 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹6,377.2 Cr | -14% | -7% | 22.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -14% |
-7% |
22.8% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses